Skip to main content

Table 4 Risk factors for 30 day mortality in patients treated with carbapenems

From: Comparison of therapy with β-lactam/β-lactamase inhibitor combinations or carbapenems for bacteraemia of nonurinary source caused by ESBL-producing Escherichia coli or Klebsiella pneumoniae

  Univariate analysis Multivariate analysis Univariate analysis Multivariate analysis
Variables P HR (95%CI), P Adjusted P Adjusted HR (95%CI), P
Age 0.021 0.94 (0.90–0.98), 0.005 0.254  
Leukemia 0.064 8.64 (1.60–46.47), 0.012 0.036 11.35 (1.17–109.83), 0.036
Pitt bacteremia score 0.320 1.45 (1.08–1.96), 0.014 0.969  
aCCI 0.640   0.794  
SOFA score 0.731   0.462 0.74 (0.38–1.44), 0.378